Art. 107e Directive (EU) 2001/83

In forcesince 20 Jan 2011cited 11×
1.

A single assessment of periodic safety update reports shall be performed for medicinal products authorised in more than one Member State and, in the cases of paragraphs 4 to 6 of Article 107c, for all medicinal products containing the same active substance or the same combination of active substances and for which a Union reference date and frequency of periodic safety update reports has been established.

The single assessment shall be conducted by either of the following:

(a)

a Member State appointed by the coordination group where none of the marketing authorisations concerned has been granted in accordance with the centralised procedure provided for in Chapter 1 of Title II of Regulation (EC) No 726/2004; or

(b)

a rapporteur appointed by the Pharmacovigilance Risk Assessment Committee, where at least one of the marketing authorisations concerned has been granted in accordance with the centralised procedure provided for in Chapter 1 of Title II of Regulation (EC) No 726/2004.

When selecting the Member State in accordance with point (a) of the second subparagraph, the coordination group shall take into account whether any Member State is acting as a reference Member State, in accordance with Article 28(1).

2.

The Member State or rapporteur, as appropriate, shall prepare an assessment report within 60 days of receipt of the periodic safety update report and send it to the Agency and to the Member States concerned. The Agency shall send the report to the marketing authorisation holder.

Within 30 days of receipt of the assessment report, the Member States and the marketing authorisation holder may submit comments to the Agency and to the rapporteur or Member State.

3.

Following the receipt of the comments referred to in paragraph 2, the rapporteur or Member State shall within 15 days update the assessment report taking into account any comments submitted, and forward it to the Pharmacovigilance Risk Assessment Committee. The Pharmacovigilance Risk Assessment Committee shall adopt the assessment report with or without further changes at its next meeting and issue a recommendation. The recommendation shall mention the divergent positions with the grounds on which they are based. The Agency shall include the adopted assessment report and the recommendation in the repository set up under Article 25a of Regulation (EC) No 726/2004 and forward both to the marketing authorisation holder.

The 10 that are cited most themselves, of 11.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…286267Law

    … opdaterede sikkerhedsindberetninger, der vedrører mere end én markedsføringstilladelse i overensstemmelse med artikel 107e, stk. 1, i direktiv 2001/83/EF, som omfatter mindst en markedsføringstilladelse, der er udstedt i henhold til …

  • Regulation (EU) 2019/51Law

    … for tjenester, der ydes af koordinationsgruppen i forbindelse med udførelsen af dens opgaver i overensstemmelse med artikel 107c, 107e, 107g, 107k og 107q i direktiv 2001/83/EF d) afgifter for andre tjenester, som agenturet yder e) …

  • Gesetz über den Verkehr mit Arzneimitteln63dLaw

    … Unbedenklichkeitsberichte in der Zulassung festgelegt sind, gilt für die Beurteilung das Verfahren nach den Artikeln 107e und 107g. (6) Die Erfüllung der Verpflichtungen nach den Absätzen 1 bis 4 kann durch schriftliche Vereinbarung …

  • Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 Decembe…1Law

    … pododstavec se vztahuje rovněž na práci zpravodajů v koordinační skupině při plnění jejích úkolů podle článků 107c, 107e, 107g, 107k a 107q směrnice 2001/83/ES.“ 16) V článku 64 se odstavec 2 mění takto: a) písmeno …

  • Regulation (EU) 2024/568Law

    … avgift på 34100 EUR ska tillämpas per förfarande för bedömning av de periodiska säkerhetsrapporter som avses i artiklarna 107e och 107g i direktiv 2001/83/EG och i artikel 28 i förordning (EG) nr 726/2004. Ersättningen för …

  • Arzneimittelgesetz75lLaw

    … Dies gilt auch im Fall einer einheitlichen Beurteilung nach Art. 107e der Richtlinie 2001/83/EG.

  • Judgment of the General Court (Fourth Chamber) of 19 September 2019. GE Healthcare A/S v European Commission.Decision

    Next, it should be observed that, according to Article 107(e)(2) and (3) of Directive 2001/83, the single assessment procedure for PSURs includes the preparation of a report by a rapporteur within 60 days of receipt of the PSURs; the …

    19 Sep 2019 · 62017TJ0783

  • BMGBGebVLaw

  • BMGBGebVLaw

    … bereits Gegenstand einer einheitliche Beurteilung der regelmäßigen aktualisierten Unbedenklichkeitsberichte nach den Artikeln 107e und 107g der Richtlinie 2001/83/EG war | 1 300 10.2 | Bei einem PSUR nach § 63d Absatz 5 AMG, soweit er …

  • Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018…1Law

    … 2019/6; and for services provided by the coordination group as regards the fulfilment of its tasks in accordance with Articles 107c, 107e, 107g, 107k and 107q of Directive 2001/83/EC; (d) charges for other services provided by the …